SCHEDULE 13G Filed 2026-10-14 Event — SEC 0001104659-26-115801 →

Coastlands Capital LP → iBio, Inc. IBIO

Stake: — Shares: — Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 6.17

4,202,419 shares short · -14.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-05-18	Stoner Elizabeth	director	Award	60,000	$1.42	$85K

Other 13D/G Filings on iBio, Inc.

Filed	Form	Filer	Stake	Shares
2020-08-13	SC	Eastern Capital LTD	—	—	view →
2020-08-11	SC	Eastern Capital LTD	—	—	view →
2020-03-31	SC	Eastern Capital LTD	—	—	view →
2020-03-05	SC	Eastern Capital LTD	—	—	view →
2020-01-31	SC	Eastern Capital LTD	—	—	view →
2019-01-03	SC	DART KENNETH BRYAN	—	—	view →
2018-07-13	SC	Eastern Capital LTD	—	—	view →

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13G	Frazier Life Sciences Acquisition Corp. II	—	—	view →
2026-10-07	SCHEDULE 13G	OnKure Therapeutics, Inc.	—	—	view →
2026-10-05	SCHEDULE 13G	Pyxis Oncology, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G/A	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →